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The tripeptide glutathione is proposed to be protective against a number of chronic diseases including
cardiovascular disease and cancer. However, there have been few studies of plasma glutathione levels in
humans and in those studies the numbers of participants have been very small. In an exploratory analysis
the determinants of plasma total glutathione (GSH,) were investigated in a group of 100 volunteers aged
1-1
years in Atlanta, Georgia, USA during June and July 1989. Data on demographic and healthrelated factors were collected by interview and plasma GSH, was measured using a recently modified
laboratory method. The mean concentration of plasma GSH, for all 100 participants was 761 pg/l, with
a standard deviation of 451 pg/l, a range of 86-2889 pg/l and a median of 649 pg/L Men had
significantly higher levels of plasma GSH, than women (924 v. 692 pg/l; P = 0.006). Seventh-day
Adventists participating in the present study had higher plasma GSH, levels than other subgroups defined
by race and/or religion. Among Seventh-day Adventists consumption of a vegetarian diet was associated
with increased plasma GSH, concentration (P= 0.002). Plasma GSH, levels also appeared to vary by
race, but relationships with race could not be clearly disassociated from relationships with religion.
Among white participants plasma GSH, concentration decreased with age in women but increased with
age in men (P= 0-05). Few other factors were associated with plasma GSH, concentration, although use
of oral contraceptives (P = 0.10) was somewhat associated with decreased plasma CSH, levels. These
findings suggest that plasma GSH, levels may vary with several demographic and health-related
attributes and support the need for further research on this potentially important disease-preventive
compound.
Plasma glutathione : Disease prevention: Humans

The tripeptide glutathione plays a central role in preventing cellular injury and
mutation (Cerutti, 1985; Wefers & Sies, 1988; Stevens & Jones, 1989; Bendich, 1990) and
may be a protective factor in cancer and aging (Ames, 1983; Cross et al. 1987), cardiovascular disease (Cross et al. 1987) and the immune dysfunction of HIV infection (Buhl
et al. 1989). Although all mammalian cells are capable of glutathione synthesis (Meister,
1989), the liver is the major source of plasma glutathione (Lauterburg et al. 1984a) and
orally administered glutathione increases plasma glutathione concentrations both in
animals (Hagen et al. 1990; Aw et al. 1991) and in humans (Hagen & Jones, 1989). Since
epithelial cells are capable of glutathione uptake from plasma (Shan et al. 1990; Aw et al.
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1991), it is possible that people with higher plasma concentrations are at reduced risk of a
number of chronic diseases, including epithelial cell cancers. Despite this potential
importance there have been few studies characterizing plasma glutathione concentration in
healthy humans and sample sizes have been limited to between five and thirty subjects
(Owens & Belcher, 1965; Hagenfeldt et al. 1978; Wendel & Cikryt, 1980; Chawla et al.
1984; Lauterburg et al. 19846; Beutler & Gelbart, 1985; Burgunder & Lauterburg, 1986;
Buhl et al. 1989; Hagen & Jones, 1989). Because of the limited information available and
the potential importance of plasma glutathione in disease prevention, we undertook an
exploratory study to describe its association with demographic and health-related
characteristics in a diverse group of 100 healthy human volunteers.
METHODS

Selection of study participants
Study participants were recruited primarily from among students, faculty and staff of the
Emory University School of Medicine, the American Cancer Society and the US Centers
for Disease Control. Because Seventh-day Adventists have been found to be at reduced risk
of several cancers and other chronic diseases (Phillips, 1975; Phillips et al. 1978) and
because they tend to differ from the general population with regard to diet and other
health-related characteristics (Phillips, 1975; Beeson et al. 1989), subjects were also
recruited from an Atlanta area Seventh-day Adventist congregation. Current smokers were
excluded because smoking appears to modify relationships between serum nutrients and
dietary factors (Hunter, 1990). Individuals with major illnesses or taking medication which
could potentially affect serum or plasma nutrient levels were also excluded from the study.
Medication resulting in exclusion included antibiotics, prednisone, cortisone and
medication for conditions such as gout, diabetes, hypertension and high serum cholesterol.
Interviewing and blood collection took place between 7 June, 1989 and 31 July, 1989.
A total of 131 eligible people volunteered to participate in the study. Plasma total
glutathione (GSH,) analyses were completed on 123 of these respondents. Twenty-three
plasma GSH, values were excluded due to sample deterioration or suspected haemolysis
from visual inspection of the plasma sample. Participants excluded from these analyses did
not differ by race, sex or age from those included. The analyses presented here were
conducted, therefore, using data from the 100 volunteers with completed interviews and
valid plasma GSH, measurements.
Interview data
After informed consent was obtained, information about health risk factors was collected
by personal interview using the Health Habits and History Questionnaire (HHHQ)
developed by Block and colleagues (Block, 1989) at the US National Institutes of Health.
The HHHQ was developed and validated for epidemiological studies of diet, health-related
factors and cancer. Demographic information obtained included the respondent’s age,
race, sex, marital status, education level and employment status. Data were also collected
on a number of health-related characteristics such as former use of cigarettes, current
consumption of alcohol, usual amount of sleep and exercise, current use of medication and
current or past medical conditions. Trained interviewers used a computerized version of the
questionnaire to enter the self-reported responses directly into a personal computer.
Immediately after completion of the interview a non-fasting blood sample was collected
from the study participants. Blood collection was obtained by routine venepuncture, using
a 19 gauge butterfly needle to avoid haemolysis. Valid sampling for glutathione requires that
haemolysis be avoided because erythrocytes contain large amounts of glutathione that does
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Table 1. Demographic characteristics of the study participants
Men
Demographic
characteristic
Total
Age category (years)
18-29
3&39
40-6 1
Race
White
Non-white*
Seventh-day
Adventist
No
Yes
Education level
High School
College
Advanced degree
Employment status
Employed
Student
Other?

*
t

Women

n

YOtotal

n

% total

30

100.0

70

100.0

13
7
10

43.3
23.3
33.3

21
24
25

30.0
34.3
35.7

23
7

76.7
23.3

49
21

70.0
30.0

27
3

90.0
10.0

61
9

87.1
12.9

1
5
24

3.3
16.7
80.0

8
27
35

11.4
38.6
50.0

21
7
2

70.0
23.3
6.7

57
11
2

81.4
15.7
2.9

Includes black (three men, seventeen women), hispanic (one man), and asian (three men, four women) races.
Includes retired (one man), unemployed (one man, one woman), and homemakers (one woman).

not readily exchange with the extracellular pool and, thus, may not be available for utilization
by other tissues (Lash & Jones, 1985).

Laboratory analyses
For the present study we measured plasma GSH,, a mixture of reduced glutathione and all
disulphide forms. To obtain these measurements a 2 ml blood specimen was collected into
a tube containing 100 pl heparin ( 2 mg/ml) in normal saline (9 g NaCl/I) to prevent
coagulation and 400 pl 10 mM-1,lO-phenanthroline in normal saline to prevent autooxidation. This tube was immediately centrifuged in a Fisher microcentrifuge for 0.5 min
to obtain plasma. 5-Sulphosalicylic acid (100 mg/ml; 250 pl) was added to 500 pl of the
plasma supernatant fraction. The tube was then placed on dry ice for transport to the
laboratory for analysis.
In the laboratory 50 pl 10 M-NaOH was added to neutralize the acid and 100 pl 10 mMdithiothreitol in 0.1 M-NaH,PO, (pH 6.0) was added to release glutathione from all disulphide forms. After 15 min of incubation at room temperature, 500 p1 of a solution of 2
parts methanol and 1 part chloroform was added to remove lipids. The tubes were centrifuged for 2 min and the aqueous phase was drawn off and treated with 500 pl trichloracetic
acid (300 mg/ml) to remove the protein. Following centrifugation for 2 min the supernatant
fraction was drawn off. Iodoacetic acid (40 p ~100
; p1) and 1 M-KOH-K~CO,(pH 8.0; 150
pl) were added to 500 pl supernatant fraction, which was than incubated for 1 h at room
temperature. l-Fluoro-2,4-dinitrobenzene
(15 pl/ml; 500 pl) in absolute ethanol and 1 MKOH-K,CO, (pH 8.0; 50 pl) were added to the supernatant fraction, which was incubated
for 4 h at room temperature. The glutathione derivative was determined by the HPLC
method of Reed et al. (1980), with minor modifications by Lash & Jones (1985).

Downloaded from https://www.cambridge.org/core. IP address: 71.201.188.217, on 01 Jul 2021 at 14:36:49, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19930175

PLASMA TOTAL GLUTATHIONE I N HUMANS

E. W. F L A G G A N D O T H E R S

Statistical analyses
The overall distribution of plasma GSH, was characterized in the study participants by
calculating the mean, standard deviation, median and range of values for all 100 subjects.
To determine whether the plasma GSH, concentration was normally distributed the data
were plotted in a normal probability plot (Neter et al. 1985) and a Kolmogorov-Smirnov
goodness of fit D statistic was calculated (Zar, 1984). Because the distribution of plasma
GSH, concentration was skewed the values were log,-transformed to produce normally
distributed data for further analyses.
In order to compare plasma GSH, concentrations among study subgroups defined by the
demographic and health-related characteristics of interest, mean values for the subgroups
were calculated using log,-transformed data. Because the study participants were volunteers,
and, therefore, cannot be assumed to represent the population from which they were
drawn, statistical tests and 95 YOconfidence intervals for subgroup means were based on the
mean square error (MSE) from analysis of variance (ANOVA) for unbalanced data, which
gives equal importance to all analysis subgroups (Neter et al. 1985). Geometric means for
these subgroups and associated upper and lower 95 YOconfidence bounds were calculated
by taking the antilogs of log,-transformed data (Flanders et al. 1992).
The sex- and/or age-adjusted associations between demographic and health-related
characteristics and plasma GSH, concentration were examined using linear-regression
models which incorporated indicator variables for the factors of interest as well as sex
and/or age indicators (Neter et al. 1985). Factor level (i.e. subgroup) means with their
standard errors were calculated using the variance-covariance matrix values and beta
parameter estimates from the best fitting linear-regression model and substituting the entire
group’s means for sex and/or age variables in the X matrix of constants. Confidence
intervals (95 %) about adjusted factor level means were calculated using adjusted standard
errors.
Statistical significances of differences between geometric means were determined by
taking differences between means from log,-transformed data and calculating the standard
errors of the differences based on the MSE. Subgroup comparisons which were adjusted for
sex and/or age category were similarly obtained using adjusted means and adjusted
standard errors. Bonferroni and Tukey procedures were used to correct for multiple
comparisons (Neter et al. 1985).
RESULTS

The study participants were predominantly female, white, under the age of 40 years, welleducated and employed (Table 1). There was little difference between men and women
except that men in the present study had higher levels of education (P= 0.02), and women
were somewhat more likely to be single, divorced, widowed or separated (P= 0.16).
Relatively few Seventh-day Adventists participated in the present study.
For the 100 participants the mean plasma GSH, concentration was 761 pg/l with a
standard deviation of 451 pg/l. Plasma GSH, levels ranged from 86 to 2889 pg/l with a
median value of 649 pg/l. For men the mean plasma GSH, concentration was 924 pg/l,
while for women the mean was 692 pg/l (P = 0.006). Differences in plasma GSH, level by
race and by Seventh-day Adventist status could not be evaluated completely because all
Seventh-day Adventists included in the present study were black, and because no black men
participated in the present study who were not Seventh-day Adventists. Comparisons were
made, therefore, among selected subgroups using the MSE based on all sample observations
(Neter et al. 1985). Among men and women, Seventh-day Adventists had higher plasma
GSH, levels than did other race/religion subgroups. Among black women, Seventh-day
Adventists were found to have much higher levels of plasma GSH, than non-Seventh-day
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Table 2. Mean plasma total glutathione (GSH,) concentration of the study participants,
by race/Seventh-day Adventist (SDA) status and sex*
Plasma GSH, (/*g/l)
Men

n
Black SDA
3
Other Non-SDAt 4
White Non-SDA 23
Black Non-SDA
0
Total
30

Women

Mean

Geometric
mean

95% CI for
geometric
mean

1479
1099
822

1301
1092
745

7362298
667-1787
6 0 6 914

-

~

924

829

-

682-1006

n

Mean

Geometric
mean

__
95% CI for
geometric
mean

9
4
49
8
70

983
873
668
420
692

923
772
573
397
594

665-1282
471-1263
498- 660
280- 562
5 2 4 615

CI, confidence intervals.
* For details of procedures, see pp. 798-800.
t Includes Hispanic (one man) and Asian (three men, four women) races.

Table 3. Mean plasma total glutathione (GSH,) concentration by dietary status for black
Seventh-day Adventists among the study participants*
Plasma GSH, (/*g/l)

Vegetarian
Non-vegetarian

n

Mean

Adjusted?
geometric mean

6
6

1440
773

1388
728

95 % CI for
adjusted?
geometric mean
(1 127-1710)
(591- 897)

CI, confidence intervals.
* For details of procedures, see pp. 798-800.
t Adjusted for sex.

Adventists ( P = 0.003 ; Table 2). White non-Seventh-day Adventist women tended to have
higher concentrations of plasma GSH,than did black non-Seventh-day Adventist women
( P = 0.16). Among whites only, plasma GSH, levels were somewhat higher for men than
for women (P= 0.12).
Too few whites and non-Seventh-day Adventists consumed a vegetarian diet for a
complete analysis of this factor among all study participants. However, among the twelve
Seventh-day Adventists participating in the present study, half consumed a vegetarian diet.
When adjusted for sex, Seventh-day Adventists on a vegetarian diet had higher levels of
plasma GSH, than Seventh-day Adventists who were not vegetarians (P = 0.002; Table 3).
Because of the heterogeneity of relationships between plasma GSH, concentration and
race/Seventh-day Adventist status, and because of the small number of non-white men in
the present study, further analyses were restricted to data collected on whites only.
The relationship between age and plasma GSH,concentration appeared to be modified
by sex. Plasma GSH,levels increased with age in men but declined with advancing age in
women (sex x age P = 0.05; Table 4). There was essentially no variation in plasma GSH,
levels among groups defined by the demographic characteristics of marital status,
education and employment status (values not shown).
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Table 4. Mean plasma total glutathione (GSH,) concentration for white men and women
among the study participants, by age and sex*
Plasma GSH, f$g/l)
Men
Age category
(years)

n

19-29
3G39
4G58

8
7
8

Women

Mean

Geometric
mean

95% CI for
geometric
mean

n

630
881
961

596
783
890

4 17-852
534-1148
623-1273

15
15
19

Geometric
Mean
mean
862
596
571

721
505
529

95% CI for
geometric
mean
555-936
389-656
42G668

CI, confidence intervals.
* For details of procedures, see pp. 798-800

Table 5. Mean plasma total glutathione (GSH,) concentration among white study
participants, by health conditions and health practices*
Plasma GSH, f$g/l)

Former cigarette smoker1
No
Yes
Currently taking oral
contraceptives$
No
Yes
Body mass index11
Normal
Overweight
Takes vitamins
No
Yes: Irregular
Regularly
Consumes alcohol7
Never
Yes, Ever
Usual exercise
More than once
weekly
Once weekly
Less than once
weekly

95% CI for
adjusted?
geometric mean

n

Mean

Adjusted?
geometric mean

36
13

71 1
548

565
596

470-680
432-822

18
3

871
462

747
417

58G961
225-773

58
14

725
68 1

616
654

538-706
496-864

30
21
21

823
558
724

718
501
634

596-865
401-625
510-788

8
64

610
730

604
626

42G-869
552-709

30

854

710

591-854

9
33

550
637

502
587

360-700
490-704

CI, confidence intervals.
* For details of participants and procedures, see pp. 798-800.
t Geometric means adjusted for sex and age in two categories (18-34 years and 35 years or older). For analyses
restricted to a single sex, adjustment is for age only.
1 Among women, since only one man was a former cigarette smoker.
$ Among women aged 18-34 years only. The geometric mean is unadjusted.
11 (weight (kg))/(height (m))'. Overweight = BMI 2 27.8, men and BMI 2 27.3, women.
11 Includes consumption of beer, wine or spirits.
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Table 6. Mean plasma total glutathione (GSH,) concentration among white study
participants, by time interval between last meal and blood sampling and by time of day the
blood sample was withdrawn*
Plasma GSH, @g/I)

Time interval between last
meal and blood sampling
0-1 h 59 min
2-3 h 59 min
4 5 h 59 min
6+ h
Time of day of blood sampling
(hours)
09.30-1 1.29
11.3cL13.29
13.3sl5.29
15.3cLl7.30

95% CI
adjusted?
geometric mean

n

Mean

Adjusted?
geometric mean

13
34
15
9

638
695
796
813

590
584
708
713

444783
489-696
542-924
503-1010

31
17
11
13

666
748
889
652

578
69 1
822
527

485-690
544876
609-1 109
395-704

C1, confidence intervals.
* For details of participants and procedures, see pp. 798-800.

t

Geometric means adjusted for sex and age in two categories (18-34 years and 35 years or older).

There was little variation in plasma GSH,levels by other health characteristics and
practices (Table 5). Among women, former use of cigarettes was not associated with plasma
GSH, level (P = 0.79). In women under 35 years, oral contraceptive users appeared to have
lower levels of plasma GSH,( P = 0.10). Body mass index (P = 0.80) and usual level of
exercise (P = 0.40) were unrelated to plasma GSH, concentration. Participants who
consumed vitamins on an irregular basis had lower plasma GSH,levels than non-users and
regular vitamin consumers (P = 0.07), but this affect did not appear to be consistent across
all sex and age categories (category-specific data not shown). Alcohol consumers did not
have reduced levels of plasma GSH, (P = 0.54). Other health-related factors which
appeared unrelated to plasma GSH, concentration included usual amount of sleep, family
history of cancer, and current minor medical conditions such as asthma or hay fever (values
not shown).
Two other factors which were evaluated in relation to plasma GSH,levels were timeinterval elapsed between last meal and blood sampling, and the time of day the blood
sample was withdrawn (Table 6).Plasma GSH,level varied little by either factor (P > 0.50).
Although plasma GSH,concentration appeared to increase somewhat with increasing
duration between last meal and blood sampling, confidence intervals about the sex- and
age-adjusted geometric means overlapped widely. There was no apparent trend or
difference in mean plasma GSH,level with time of day the blood collection took place,
although plasma GSH, concentrations were somewhat higher in the early afternoon.
DISCUSSION

In the present exploratory study of 100 healthy volunteers we found a wide range of plasma
GSH,levels which appeared to vary by sex, age, and possibly by race. In addition, Seventhday Adventists had higher levels of plasma GSH,than did non-Seventh-day Adventists,
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while among Seventh-day Adventists vegetarians appeared to have the highest concentrations of plasma GSH,.
Glutathione may be important in disease prevention because of its role in preventing
cellular injury and mutation by detoxifying xenobiotics (Stevens & Jones, 1989) and by
protecting cells against oxidative damage, both directly as an antioxidant (Cerutti, 1985)and
indirectly by maintaining other cellular antioxidants in a functional state (Wefers & Sies,
1988; Bendich, 1990). In addition, a number of studies indicate that glutathione may be
involved in various aspects of the immune response, including T-cell and lymphocyte
activation and proliferation (Hamilos & Wedner, 1985; Droge et al. 1986).
Although no prospective studies have examined the relationship between plasma
glutathione status and disease risk, it has been shown that alcoholic subjects (Chawla et al.
1984; Lauterburg et al. 1984b), patients with malignancies (Beutler & Gelbart, 1985), HIVseropositive individuals (Buhl et al. 1989) and those ingesting acetaminophen (Lauterburg
et al. 19848; Beutler & Gelbart, 1985) or diets deficient in ascorbic acid (Henning et al.
1991) have lower levels of plasma glutathione than do healthy subjects.
Plasma GSH, levels were consistent with values reported in previous smaller studies of
healthy humans. In those studies the mean values of plasma glutathione vary considerably,
ranging from 104 to 5465 pg/l (Owens & Belcher, 1965; Hagenfeldt et al. 1978; Wendel &
Cikryt, 1980; Chawla et al. 1984; Lauterburg et al. 19848; Beutler & Gelbert, 1985;
Burgunder & Lauterburg, 1986; Buhl et al. 1989; Hagen & Jones, 1989). This wide
variation between studies may be due principally to differences in the forms of glutathione
that were measured and in the laboratory methods used. In addition, because the
concentration of glutathione in erythrocytes is much greater than in plasma (Beutler &
Gelbart, 1985; Lash & Jones, 1985), small amounts of haemolysis can result in artifactually
high plasma glutathione levels. For the present report all plasma samples with apparent
haemolysis were excluded from the analyses.
In the present study men had much higher levels of plasma GSH, than women. Studies
of mice have demonstrated significantly higher levels of plasma glutathione in males than
in females (Hirayama et al. 1987; Taniguchi et al. 1989), although this association has not
been found in rats (Taniguchi et a/. 1989). Two previous studies in humans, each with thirty
participants, did not report a difference in plasma glutathione concentrations between men
and women (Wendel & Cikryt, 1980; Beutler & Gelbart, 1985). Reasons for differences in
glutathione levels by sex are not well understood, but research with animals indicates that
plasma glutathione level may be affected by sex hormones. In mice the turnover rates of
hepatic and renal glutathione appear to be significantly faster in males compared with
females, with male castration decreasing these rates to levels approaching those of females.
Several researchers have proposed therefore, that glutathione metabolism, secretion and
transport may be influenced by sex hormones (Hirayama et al. 1987; Taniguchi et al. 1989).
We found that, among young women, use of oestrogen-containing oral contraceptives was
associated with lower plasma GSH, levels, suggesting that the relationship between
hormonal status, sex and plasma GSH, concentration may be complex in humans. We
could identify no other likely explanations for the observed difference in plasma GSH, by
sex. Men and women in the present study were similar in most characteristics except
education and marital status, and plasma GSH, concentration was not associated with
those factors.
Among whites the association between age and plasma GSH, concentration appeared to
be modified by sex. Several studies of mice have demonstrated that tissue glutathione
concentrations decline with age (Hazelton & Lang, 1980; Stohs et aE. 1982), but sex-specific
comparisons were not presented. The two previous studies in humans which examined sex
differences in plasma glutathione concentration did not look at the combined effect of age
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and sex (Wendel & Cikryt, 1980; Beutler & Gelbart, 1985), although one study reported no
overall relationship between plasma glutathione level and age (Beutler & Gelbart, 1985). We
know of no other nutritional biochemical measures that vary by age and sex in this manner
and do not know why age might influence plasma GSH, levels differently in men and women.
This relationship should be considered in future studies of plasma glutathione in humans.
Plasma GSH, concentration appeared to vary substantially by race and/or membership
in the Seventh-day Adventist church, although we could not distinguish clearly between
these factors. Diet may account partially for this relationship, as the Seventh-day Adventist
religion endorses adherence to a lacto-ovovegetarian diet and other dietary restrictions
(Phillips, 1975; Beeson et al. 1989). The Seventh-day Adventists participating in the present
study who consumed vegetarian diets had much higher levels of plasma GSH, than nonvegetarian Seventh-day Adventists. Although this comparison was based on small numbers
of subjects in each group, the difference in mean plasma GSH, concentration between these
two groups was striking.
Diet may affect plasma glutathione level in a number of ways. In rodents, diets low in
the glutathione-precursor amino acids methionine and cysteine have been shown to
decrease hepatic glutathione concentration (Sendelbach et al. 1990) while a cysteine-rich
diet increases liver glutathione levels (Bounous et al. 1989). Hepatic glutathione
concentration has been found to decrease in riboflavin-deficient rats (Taniguchi et al. 1989).
Although GSH is synthesized endogenously from its precursor amino acids (Meister, 1989),
animal studies have shown that exogenous glutathione is transported into the cells of the
small intestine as an intact tripeptide (Hagen & Jones, 1987). Orally administered
glutathione increases plasma glutathione levels in rats (Hagen et al. 1990; Aw et al. 1991)
and in humans (Hagen & Jones, 1989).
Dietary glutathione is available from a variety of food sources. Meats contain the highest
concentrations, with large amounts in fruits and vegetables and little or none in grains and
dairy products (Jones et al. 1992). Thus, differences in diet may explain some differences in
plasma levels. However, because of the relatively high concentrations of glutathione and its
precursor amino acids in meats (Jones et al. 1992), it is uncertain that vegetarian Seventhday Adventists consume more glutathione precursor amino acids or more intact glutathione.
To our knowledge, no studies in humans have yet examined the relationship between diet and
plasma glutathione concentration.
Other more complex dietary or health-related factors may affect plasma glutathione levels.
In the present study participants who took vitamins irregularly appeared to have lower levels
of plasma GSH, than those not taking any vitamins or taking vitamins on a regular basis.
This effect, however, was not consistent across all sex and age categories examined, and
may be spurious or due to other lifestyle factors associated with irregular vitamin usage.
Although a recent study of healthy men receiving ascorbic acid-deficient diets demonstrated
decreased plasma glutathione levels (Henning el al. 1991), the relationships between the
plasma antioxidants ascorbic acid, a-tocopherol, /3-carotene and glutathione appear to be
quite complex (Wefers & Sies, 1988; Frei et al. 1989; Bendich, 1990) and it is unclear whether
ingestion of vitamins, particularly antioxidants, should theoretically increase or decrease
plasma GSH, levels.
Among white participants plasma GSH, concentration did not vary significantly by
either time-interval between last meal and blood sampling, or time of day that the blood
sample was taken. However, a slight increasing trend in plasma GSH, level was observed
with increasing duration between the most recent meal and blood sampling. In rats fasting
appears to increase hepatic glutathione synthesis (Lauterburg & Mitchell, 1981) with a
concomitant increase in efflux of the reduced (GSH) and oxidized (GSSG) forms of
glutathione (Lauterburg et al. 1984a), and it is possible that a similar phenomenon exists
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in humans. Although diurnal variations in rat blood glutathione levels have been observed,
these fluctuations appear to be limited to erythrocyte glutathione (Calcutt, 1967).
Several limitations to the present study should be noted. Although the study is, to our
knowledge, the largest conducted to date which examines plasma glutathione concentrations
in free-living humans, the numbers of subjects in the analysis subgroups become small with
increasing number of simultaneously examined factors. This reduces the statistical power
of subgroup comparisons, and for this reason we chose to adjust only for sex and age, the
two most important factors associated with plasma GSH, level.
An additional limitation is that most participants in the present study were recruited
from among employees and students in health-related organizations. Other study subjects
were members of a Seventh-day Adventist congregation. Both groups of participants are
likely to differ from members of the general population on a number of health-related
factors. This, along with the self-referred nature of the study participants, precludes
generalization of these findings to the population at large.
It is also important to note that in the present study we assayed plasma GSH,, which
consists of GSH and all disulphide forms, including mixed disulphides with cysteine
and protein. Many previous investigations of plasma glutathione assessed a combination
of GSH and GSSG forms of glutathione, but did not assay for the presence of plasma
glutathione in the form of mixed disulphides. In rats, however, approximately 70% of
plasma glutathione exists in the protein-bound form (Lash & Jones, 1985), and recent
studies in both rats and humans have shown that, like glutathione, protein-bound
glutathione appears to increase in response to orally administered glutathione (Hagen &
Jones, 1989; Aw et al. 1991). Protein-bound glutathione may participate in regulating the
biological activity of plasma peptide hormones and immunoglobulins and receptor binding
to plasma membranes (Lash & Jones, 1985). Because of this, plasma GSH,, which includes
the potentially biologically important disulphide forms, was assayed in the present study.
In conclusion, from the present study it is apparent that plasma GSH, concentrations
vary widely in humans and are influenced by sex and age. Because research indicates a
vegetarian diet is associated with reduced risk of some chronic diseases (Dwyer, 1988;
National Research Council Committee on Diet and Health, 1989) and because Seventh-day
Adventists are also at reduced risk of certain chronic diseases (Phillips, 1975; Phillips et al.,
1978), it was particularly intriguing that plasma GSH, levels were higher among Seventhday Adventists and among vegetarians. Because glutathione has several biological functions
that may influence risk of chronic diseases, further studies are needed to examine factors
affecting plasma GSH, status, particularly dietary practices, and the relationship between
plasma GSH, and subsequent disease incidence.
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requirements for the PhD degree at Emory University and was supported in part by cancer
education grant CA17998-15 from the US National Institutes of Health. Dean P. Jones
was supported in part by grant HL-39968 from the US National Institutes of Health.
J. William Eley is a recipient of an American Cancer Society Career Development Award.
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